Dansk Pharmaceuticals India Private Limited - Company Profile

It is a pharma private limited company based in Faridabad, Haryana, India, established in 2020.
2020 Faridabad, Haryana, India Active
Last Updated:
Access Report
About Dansk Pharmaceuticals India Private Limited

Dansk Pharmaceuticals India Private Limited, a active private limited company, was established on 02 June 2020 in Faridabad, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230HR2020PTC086501. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.50 M.

Its leadership includes Ravipal Singh Rulania (Director), Harinder Singh (Director), Sunil Kumar (Director). Past directors included Harinder Singh, Urmila Pandey, Gautam Gupta. It holds no open charges and ₹5.25 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at House No. 2469/D Sector-64 Faridabad, Faridabad, Haryana, 121004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230HR2020PTC086501

  • Registration Number

    086501

  • Incorporation Date

    02 June 2020

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹1.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 1.50 M
  • Company Age 5 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 5.25 M
  • Revenue Growth **** 2.85%
  • Profit Growth **** -196.20%
  • Ebitda **** -216.74%
  • Net Worth -577.29%
  • Total Assets **** 249.15%
Company report

Dansk Pharmaceuticals India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dansk Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dansk Pharmaceuticals India Private Limited?
Current Directors
Name Designation Appointment Date Status
Ravipal Singh Rulania Director 09 Apr 2025 Current
Harinder Singh Director 01 Feb 2021 Current
Sunil Kumar Director 02 Jun 2020 Current
Kuldeep Sangwan Director 02 Jun 2020 Current
Bhagat Singh Director 15 May 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Dec 2021 Past
Pramod Abcsdd Additional Director 31 Dec 2021 Past
Pramod Abcsdd Director 08 Oct 2024 Past
Pramod Abcsdd Director 12 Apr 2025 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dansk Pharmaceuticals India.

Dansk Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.85% increase. The company also saw a substantial fall in profitability, with a 196.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 577.29%.

Dansk Pharmaceuticals India revenue growth over time
Dansk Pharmaceuticals India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 2.85%
*******
*******
*******
*******
Revenue from Operations
*******
 -6.00%
*******
*******
*******
*******
Total Assets
*******
 249.15%
*******
*******
*******
*******
Profit or Loss
*******
 -196.20%
*******
*******
*******
*******
Net Worth
*******
 -577.29%
*******
*******
*******
*******
EBITDA
*******
 -216.74%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dansk Pharmaceuticals India?

In 2022, Dansk Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹5,245,966.00

Charges Breakdown by Lending Institutions
  • Others : 0.52 Cr
Latest Charge Details
Date Lender Amount Status
25 Mar 2022 Others ₹5.25 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Dansk Pharmaceuticals India?

Dansk Pharmaceuticals India has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dansk Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dansk Pharmaceuticals India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dansk Pharmaceuticals India
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dansk Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Ravipal Singh Rulania was appointed as a Director was appointed as a Director on 09 Apr 2025 & has been associated with this company since 10 months 13 days . was recorded as a recent event.

  • Balance Sheet

    Dansk Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    The activity A charge registered on 25 Mar 2022 via Charge ID 100553451 with Others was fully satisfied on 22 Jan 2024. was completed.

  • Director Appointment

    The activity Bhagat Singh was appointed as a Director was appointed as a Director on 15 May 2022 & has been associated with this company since 3 years 9 months . was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 5.25 M with Charge ID 100553451 was registered on 25 Mar 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dansk Pharmaceuticals India Private Limited?

The CIN of Dansk Pharmaceuticals India Private Limited is U24230HR2020PTC086501.

Where is Dansk Pharmaceuticals India Private Limited headquartered?

Dansk Pharmaceuticals India Private Limited is headquartered at House No. 2469/D Sector-64 Faridabad, Faridabad, Haryana, 121004.

When was Dansk Pharmaceuticals India Private Limited incorporated?

Dansk Pharmaceuticals India Private Limited was incorporated on 02 June 2020.

Who are the current directors of Dansk Pharmaceuticals India Private Limited?

The current directors of Dansk Pharmaceuticals India Private Limited are

What is the primary industry of Dansk Pharmaceuticals India Private Limited?

The primary industry of Dansk Pharmaceuticals India Private Limited is Manufacturing.

Is Dansk Pharmaceuticals India Private Limited a listed company?

Dansk Pharmaceuticals India Private Limited is unlisted.

What is the capital structure of Dansk Pharmaceuticals India Private Limited?

The authorized capital of Dansk Pharmaceuticals India Private Limited is ₹5.00 M, and the paid-up capital is ₹1.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available